Skip to main content

US ClosedU.S. Closed

BLSM: BlossomHill Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Blossomhill Therapeutics, Inc. is a biopharmaceutical company.

52W Range

69thpctl

Volume

0.57×avg

Market Cap

606.63MUSD

P/E Ratio

-19.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

BlossomHill Therapeutics, Inc.

BLSMNASDAQ·USD·Closed

BlossomHill Therapeutics, Inc.

BLSMNASDAQ·USD·Closed

$20.86

−3.02%

$20.86

−$0.65 (3.02%)

52W Range

69thpctl

Volume

0.57×avg

Mkt Cap

606.63MUSD

P/E

-19.3TTM

Div Yield

–ann